RISANKIZUMAB INDUCTION THERAPY PROVIDES EARLY SYMPTOM IMPROVEMENTS IN ABDOMINAL PAIN AND STOOL FREQUENCY IN PATIENTS WITH MODERATE TO SEVERE CROHN’S DISEASE: RESULTS FROM TWO PHASE 3 INDUCTION STUDIES

Jean-Frédéric Colombel  ¹     Stefan Schreiber  ²     Geert R. D'Haens  ³     Joanne Rizzo  ⁴     Kristina Kligys     Jenny Griffith     Javier Zambrano     Qian Zhou     Jasmina Kalabic  ⁵     Florian Rieder  ⁶     Marla C. Dubinsky     Remo Panaccione  ^7    
1 Icahn School of Medicine at Mount Sinai, New York, United States
² University Hospital Schleswig-Holstein, Kiel University, Kiel, Germany
³ Amsterdam University Medical Center, Amsterdam, Netherlands
⁴ AbbVie Inc., North Chicago, United States
⁵ AbbVie Deutschland GmbH & Co. KG, Ludwigshafen, Germany
⁶ Cleveland Clinic, Cleveland, United States
⁷ University of Calgary, Calgary, Canada

Session
IBD (Posters)

Conference
UEG Week Virtual 2021

Citation
United European Gastroenterology Journal 2021; 9 (Supplement 8)